Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT study of imipenem plus amikacin pharmacokinetic/pharmacodynamic variability in ventilator-associated Gram-negative pneumonia
2007-005446-20Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imipenem + cilastatin, amikacin in ventilator-associated pneumonia (VAP), Gram-negative pneumonia, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2008; status: active.
02
Drugs
imipenem + cilastatinamikacin
03
Conditions
ventilator-associated pneumonia (VAP)Gram-negative pneumonia
Beyond the preview
Go deeper on 2007-005446-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005446-20.